109 related articles for article (PubMed ID: 20637613)
1. Tetrahydropyridine derivatives with inhibitory activity on the production of proinflammatory cytokines: part 3.
Nakao A; Ohkawa N; Nagasaki T; Kagari T; Doi H; Shimozato T; Ushiyama S; Aoki K
Bioorg Med Chem Lett; 2010 Aug; 20(16):4774-8. PubMed ID: 20637613
[TBL] [Abstract][Full Text] [Related]
2. Tetrahydropyridine derivatives with inhibitory activity on the production of proinflammatory cytokines: part 2.
Nakao A; Ohkawa N; Nagasaki T; Kagari T; Doi H; Shimozato T; Ushiyama S; Aoki K
Bioorg Med Chem Lett; 2010 Apr; 20(8):2435-7. PubMed ID: 20346666
[TBL] [Abstract][Full Text] [Related]
3. [The effect of the type II collagen protein from Zaocys on cytokines production by synoviocytes in rats with adjuvant arthritis].
Pang J; Li J; Wu XH; Wu HY
Zhong Yao Cai; 2009 Apr; 32(4):556-60. PubMed ID: 19645241
[TBL] [Abstract][Full Text] [Related]
4. Tetrahydropyridine derivatives with inhibitory activity on the production of proinflammatory cytokines: part 1.
Nakao A; Ohkawa N; Nagasaki T; Kagari T; Doi H; Shimozato T; Ushiyama S; Aoki K
Bioorg Med Chem Lett; 2009 Aug; 19(16):4607-10. PubMed ID: 19596194
[TBL] [Abstract][Full Text] [Related]
5. Novel p38 inhibitors with potent oral efficacy in several models of rheumatoid arthritis.
Revesz L; Blum E; Di Padova FE; Buhl T; Feifel R; Gram H; Hiestand P; Manning U; Rucklin G
Bioorg Med Chem Lett; 2004 Jul; 14(13):3595-9. PubMed ID: 15177482
[TBL] [Abstract][Full Text] [Related]
6. Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity.
Hill RJ; Dabbagh K; Phippard D; Li C; Suttmann RT; Welch M; Papp E; Song KW; Chang KC; Leaffer D; Kim YN; Roberts RT; Zabka TS; Aud D; Dal Porto J; Manning AM; Peng SL; Goldstein DM; Wong BR
J Pharmacol Exp Ther; 2008 Dec; 327(3):610-9. PubMed ID: 18776065
[TBL] [Abstract][Full Text] [Related]
7. Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology.
Patten C; Bush K; Rioja I; Morgan R; Wooley P; Trill J; Life P
Arthritis Rheum; 2004 Oct; 50(10):3334-45. PubMed ID: 15476226
[TBL] [Abstract][Full Text] [Related]
8. Effect of FR133605, a novel cytokine suppressive agent, on bone and cartilage destruction in adjuvant arthritic rats.
Yamamoto N; Sakai F; Yamazaki H; Kawai Y; Nakahara K; Okuhara M
J Rheumatol; 1996 Oct; 23(10):1778-83. PubMed ID: 8895158
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of collagen-induced arthritis in mice by a novel phosphodiesterase 7 and 4 dual inhibitor, YM-393059.
Yamamoto S; Sugahara S; Ikeda K; Shimizu Y
Eur J Pharmacol; 2007 Mar; 559(2-3):219-26. PubMed ID: 17250824
[TBL] [Abstract][Full Text] [Related]
10. Proinflammatory cytokines synergistically enhance the production of chemokine ligand 20 (CCL20) from rheumatoid fibroblast-like synovial cells in vitro and serum CCL20 is reduced in vivo by biologic disease-modifying antirheumatic drugs.
Kawashiri SY; Kawakami A; Iwamoto N; Fujikawa K; Aramaki T; Tamai M; Arima K; Kamachi M; Yamasaki S; Nakamura H; Tsurumoto T; Kono M; Shindo H; Ida H; Origuchi T; Eguchi K
J Rheumatol; 2009 Nov; 36(11):2397-402. PubMed ID: 19797510
[TBL] [Abstract][Full Text] [Related]
11. Effects of a novel tylophorine analog on collagen-induced arthritis through inhibition of the innate immune response.
You X; Pan M; Gao W; Shiah HS; Tao J; Zhang D; Koumpouras F; Wang S; Zhao H; Madri JA; Baker D; Cheng YC; Yin Z
Arthritis Rheum; 2006 Mar; 54(3):877-86. PubMed ID: 16508970
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of FK506 and methotrexate on inflammatory cytokine levels in rat adjuvant-induced arthritis.
Magari K; Miyata S; Nishigaki F; Ohkubo Y; Mutoh S; Goto T
J Rheumatol; 2003 Oct; 30(10):2193-200. PubMed ID: 14528517
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the cytokine network among tumor necrosis factor alpha, interleukin-1beta, interleukin-8, and interleukin-1 receptor antagonist in monosodium urate crystal-induced rabbit arthritis.
Matsukawa A; Yoshimura T; Maeda T; Takahashi T; Ohkawara S; Yoshinaga M
Lab Invest; 1998 May; 78(5):559-69. PubMed ID: 9605181
[TBL] [Abstract][Full Text] [Related]
14. Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes.
Xu H; He Y; Yang X; Liang L; Zhan Z; Ye Y; Yang X; Lian F; Sun L
Rheumatology (Oxford); 2007 Jun; 46(6):920-6. PubMed ID: 17314215
[TBL] [Abstract][Full Text] [Related]
15. Preferential inhibition of T helper 1, but not T helper 2, cytokines in vitro by L-826,141 [4-[2-(3,4-Bisdifluromethoxyphenyl)-2-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-phenyl]-ethyl]3-methylpyridine-1-oxide], a potent and selective phosphodiesterase 4 inhibitor.
Claveau D; Chen SL; O'Keefe S; Zaller DM; Styhler A; Liu S; Huang Z; Nicholson DW; Mancini JA
J Pharmacol Exp Ther; 2004 Aug; 310(2):752-60. PubMed ID: 15082748
[TBL] [Abstract][Full Text] [Related]
16. Sinomenine ameliorates arthritis via MMPs, TIMPs, and cytokines in rats.
Zhou H; Wong YF; Wang J; Cai X; Liu L
Biochem Biophys Res Commun; 2008 Nov; 376(2):352-7. PubMed ID: 18782565
[TBL] [Abstract][Full Text] [Related]
17. Anti-rheumatic activity of pseudoephedrine (a substituted phenethylamine) in complete Freund's adjuvant-induced arthritic rats by down regulating IL-1β, IL-6 and TNF-α as well as upregulating IL-4 and IL-10.
Ahsan H; Irfan HM; Alamgeer ; Shahzad M; Asim MH; Akram M; Zafar MS
Inflammopharmacology; 2021 Jun; 29(3):673-682. PubMed ID: 33772383
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data.
Bendele A; McAbee T; Sennello G; Frazier J; Chlipala E; McCabe D
Arthritis Rheum; 1999 Mar; 42(3):498-506. PubMed ID: 10088773
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of murine collagen-induced arthritis by a novel, potent, selective small molecule inhibitor of IkappaB Kinase 2, TPCA-1 (2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide), occurs via reduction of proinflammatory cytokines and antigen-induced T cell Proliferation.
Podolin PL; Callahan JF; Bolognese BJ; Li YH; Carlson K; Davis TG; Mellor GW; Evans C; Roshak AK
J Pharmacol Exp Ther; 2005 Jan; 312(1):373-81. PubMed ID: 15316093
[TBL] [Abstract][Full Text] [Related]
20. Surface-bound anti-type II collagen-containing immune complexes induce production of tumor necrosis factor alpha, interleukin-1beta, and interleukin-8 from peripheral blood monocytes via Fc gamma receptor IIA: a potential pathophysiologic mechanism for humoral anti-type II collagen immunity in arthritis.
Mullazehi M; Mathsson L; Lampa J; Rönnelid J
Arthritis Rheum; 2006 Jun; 54(6):1759-71. PubMed ID: 16736518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
